Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 21 for “"Amisulpride"”.
-
ESTABLISHING THE DISCRIMINATIVE STIMULUS PROPERTIES OF THE ATYPICAL ANTIPSYCHOTIC AMISULPRIDE IN C57BL/6 MICE
… PROPERTIES OF THE ATYPICAL ANTIPSYCHOTIC AMISULPRIDE IN C57BL/6 MICE Antipsychotic medications are used to treat schizophrenia. The present study used the drug discrimination paradigm to measure the subjective effects of the atypical antipsychotic amisulpride and to examine the underlying …
-
CHARACTERIZATION OF THE DISCRIMINATIVE STIMULUS PROPERTIES OF THE ATYPICAL ANTIPSYCHOTIC AMISULPRIDE IN C57BL/6 MICE
Amisulpride, a benzamide derivative, is an atypical antipsychotic drug used to treat both schizophrenia and depression. Amisulpride is a selective antagonist at dopamine D2 and D3 receptors and at serotonin 5-HT2B and 5-HT7 receptors and displays an atypical clinical profile with reduced …
-
Antidepressant-like Effects of Amisulpride, Ketamine, and Their Enantiomers on Differential-Reinforcement-of-Low-Rate (DRL) Operant Responding in Male C57/BL/6 Mice
… for the treatment of depression. Racemic amisulpride is an atypical antipsychotic that has been used at low doses to treat dysthymia, a mild form of depression, and functions as an antagonist at DA2/3, 5-HT2B, and 5-HT7 receptors. Recent preclinical studies have suggested that the S(+) …
-
Incretin dysregulation of lysyl oxidase: a new mechanism for diabetic bone disease
… further verify the effects of dopamine by using amisulpride, a dopamine receptor antagonist, to determine if amisulpride could restore bone health in streptozotocin (STZ) induced diabetic mice. For this study C57BL/6 wild type mice were used. The mice were divided at random into three groups …
-
The transport of CNS-active cationic drugs across the blood-brain barrier
… on the antipsychotic drugs haloperidol and amisulpride, both cationic drugs at physiological pH. Haloperidol, an extensively used drug both as an antipsychotic and for palliative care, has the potential to interact with other drugs at the BBB. Haloperidol was found to be a substrate for OCTs …
-
Examining the neural basis of decisionmaking using social stimuli, dopamine and oxytocin in schizophrenia
… ropinirole (0.25mg); dopamine antagonist, amisulpride (400mg), and placebo. fMRI was also performed in 42 patients with schizophrenia (SZ); and a subsample of 20 patients after treatment with oxytocin (40IU) or placebo nasal spray. Participants performed a decision-making task incorporating …
-
Identifying new small molecule inhibitors for the therapy of chronic inflammatory diseases: developing of a novel screening pipeline
… identified that a neuroleptic medication, namely Amisulpride, could downregulate hTNFtg SFs’ activation and hTNFtg polyarthritis in vivo. Importantly, the molecular mechanism of the drug was not dependent on its main known receptors DRD2, DRD3 and HTR7. By applying a click chemistry approach, we …
-
Συγκριτική κυτταρογενετική μελέτη ευρέως χρησιμοποιούμενων αντιψυχωτικών σκευασμάτων σε λεμφοκύτταρα ανθρώπου
… and the atypical antipsychotic medications are amisulpride, sulpiride, aripiprazole, ziprazidone, quetiapine and paliperidone. In our study, we used in vitro cultures of lymphocytes, extracted from the peripheral blood of healthy donors, cultivated under the presence of different concentrations …
-
Characterising the Neuropsychological Profile of Psychotic Symptoms in Alzheimer’s Disease and Imaging D2/3 Receptor Occupancy During Treatment
… with AD were recruited prior to commencing amisulpride treatment. [18F]fallypride BPND pre/post 2-8 weeks of amisulpride treatment and D2/3 occupancy was measured.<br/>ResultsNeuropsychology: Subjects with psychotic symptoms, in particular misidentification phenomena, had significantly …
-
Antipsychotics, glutamate, and the brain
… brain regions; 2) Sub-chronic administration of amisulpride increased total gray matter and putamen volume in healthy volunteers; 3) In the thalamus I found a significant association between amisulpride administration and an increase in glutamate levels corrected for voxel cerebrospinal fluid; 4) …
-
Functional and structural brain changes after dopamine D2 receptors blockade
… study in healthy volunteers who received either amisulpride 400mg or a placebo daily for seven days. T1 maps and brain volume estimation were derived from the MP2RAGE sequence. Pseudo-continuous ASL and resting-state multi-echo fMRI sequences were used to assess CBF and functional connectivity …
-
$\textbf{Neural Correlates of Motivation and Reward Learning in Healthy and Chronic Pain}$
… were engaged in a reward learning task in the amisulpride condition compared to the placebo condition. The findings indicated that antagonism of D2-receptors with amisulpride had no effect on the encoding of cues and reward prediction errors of pain relief and monetary reward in the …
-
Ανάπτυξη και επικύρωση αναλυτικών μεθοδολογιών προσδιορισμού αντικαταθλιπτικών και αντιψυχωσικών φαρμάκων σε νεκροτομικό υλικό και βιολογικά υγρά ασθενών
… antipsychotic drugs (olanzapine, haloperidol, amisulpride, risperidone, paliperidone, clozapine-with metabolite N-desmethylclozapine-, quetiapine and aripiprazole), nine antidepressants (mirtazapine, bupropion, venlafaxine, citalopram, (with metabolite N-desmethylcitalopram), paroxetine, …
-
Incretin dysregulation of lysyl oxidase: a novel mechanism for diabetic osteopenia
… osteoblasts with the dopamine receptor inhibitor amisulpride restored the impaired GIP stimulated increases in LOX expression in osteoblasts isolated from diabetic mice. This study defines a potential mechanism for diabetic bone disease and suggests that interference with dopamine signaling would …
-
Αξιολόγηση της επίδρασης ψυχοτρόπων φαρμάκων στο γενετικό υλικό ψυχιατρικών ασθενών
… haloperidol, clozapine, olanzapine, risperidone, amisulpride and aripiprazole The comparative results of this study showed that all the substances of the study in schizophrenic patients administered at doses within the recommended therapeutic range, caused cytotoxicity with a statistically …
-
Neurobiology of negative and cognitive symptoms of schizophrenia
… by administering the D2/D3 antagonist amisulpride and the D2/D3 partial agonist aripiprazole for seven days each to healthy humans in a randomised, double-blind placebo-controlled design. I find that sustained dopamine D2/D3 receptor antagonism in healthy humans results in blunted …
-
Assessing the use and effectiveness of antipsychotic medication
… lack of power precluded similar conclusions with amisulpride, clozapine, and quetiapine. In the retrospective studies, clozapine was clinically superior to other oral antipsychotics but there was no significant clinical difference between the main 3 depot or long acting antipsychotics studied. The …
-
Η φαρμακογενής υπερπρολακτιναιμία σε σχιζοφρενικούς αρρώστους: ελεγχόμενη μελέτη της ντοπαμινικής υπόθεσης
… on a PRL- raising antipsychotic (risperidone, amisulpride or haloperidole) . The mainobjective was to investigate whether cabergoline (CBG) improved on sexual functioning inpatients with hyperprolactinemia, without having unfavorable effects on their psychopathology.In total 80 patients were …
-
Using whole disease modelling to inform resource allocation decisions in schizophrenia services
… with acute episode of psychosis (Topic B); amisulpride, risperidone or olanzapine as the first-line oral antipsychotic medication for people with first-episode psychosis (FEP) (Topic C); family intervention combined with antipsychotic medication for people with FEP (Topic D); and clozapine …
Page 1 of 2